Effective measurement of risperidone treatment outcome for persons with borderline personality disorder: the UAB Borderline Rating Scale (BRS).

Trial Profile

Effective measurement of risperidone treatment outcome for persons with borderline personality disorder: the UAB Borderline Rating Scale (BRS).

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Mar 2012

At a glance

  • Drugs Risperidone (Primary)
  • Indications Borderline personality disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Mar 2012 Actual end date (October 2007) added as reported by ClinicalTrials.gov.
    • 15 Mar 2012 Additional lead trial investigator (Celia T. Huston) identified as reported by ClinicalTrials.gov.
    • 15 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top